Our Company

Good Therapeutics is a discovery-stage biotechnology company based in Seattle, WA, with $22 million in Series A funding from Codon Capital, Roche Venture Fund, Rivervest Venture Partners, Digitalis Ventures and 3x5 Partners.

Our Team
Leadership
JOHN MULLIGAN, PhDBio Picture
Founder and CEO
DIANE HOLLENBAUGH, PhDBio Picture
Head of Research
JUSTIN KILLEBREW, PhDBio Picture
Director of Immuno-Oncology Discovery
Board of Directors
JOHN MULLIGAN, PhDBio Picture
Founder and CEO
KARL HANDELSMANBio Picture
Founder & Managing Partner, Codon Capital
JOHN MCKEARN, PhDBio Picture
Managing Director, Rivervest
MONIQUE SCHIERSING, MSc MBABio Picture
Senior Investment Director, Roche Venture Fund
NICHOLAS WALRODBio Picture
Managing Director & co-founder, 3x5 Partners
Board Observer
SAM BJORKBio Picture
Principal at Digitalis

Join Us

Good Therapeutics is led by a team of energetic and experienced scientists, business leaders, and creative minds